Aim. To determine the extent of quality-of-life (KCCQ-12) recovery over 6 months of treatment in patients with ischemic cardiomyopathy (ICM), its association with the completeness of coronary revascularization, and the independent factors determining this recovery. Materials and Methods. A total of 168 patients with ICM were included in this prospective single-center study. The Heart Team assigned patients to three groups: Group 1 — complete percutaneous coronary intervention (PCI) (n=58), Group 2 — incomplete PCI (n=54), and Group 3 — optimal medical therapy (OMT) only (n=56); all patients received an SGLT2 inhibitor. Continuous outcomes were analyzed using ANCOVA adjusted for baseline values and residual SYNTAX score, while predictors of response were assessed using logistic regression. Results. At 6 months, KCCQ-12 scores increased significantly in all groups (Group 1 +14.3; Group 2 +9.5; Group 3 +9.5 points; all within-group p<0.05); 53.7–63.8% of patients achieved a clinically meaningful improvement of ≥5 points. Adjusted between-group differences in KCCQ were not significant (Groups 1 vs 3: +3.28 points; 95% CI −12.8–19.3; p=0.69). Complete revascularization was associated with an additional increase in LVEF (Groups 1 vs 3: +5.01%; 95% CI 1.17–8.84; p=0.01). Change in KCCQ showed a weak but significant correlation with change in LVEF (Spearman r=0.158; p=0.040). The only independent predictor of a ≥10-point response was a lower baseline KCCQ score (OR 0.91 per point; 95% CI 0.88–0.94; p<0.001); completeness of revascularization was not independently associated with the response. Conclusion. Against the background of SGLT2 inhibitor-based quadruple therapy, quality of life in patients with ICM improved significantly and to a similar extent regardless of the completeness of revascularization, whereas complete revascularization provided additional left ventricular reverse remodeling. The greatest quality-of-life benefit was observed in patients with the most severe symptoms at baseline, supporting personalized, patient-centered decision-making.
| Mualliflar | Fozilov, Khurshid, Abdukomilov, Abdulatif, Atamuratov, Bakhtiyor, Фозилов, Х, Абдукомилов, A, Атамуратов, Б, Fozilov, Xurshid, Abdukomilov, Abdulatif, Atamuratov, Baxtiyor |
|---|---|
| Jurnal | O‘zbekiston кardiologiyasi |
| Nashr sanasi | 2026-03-30 |
| Jild | 3 |
| Son | 1 |
| Betlar | 92-100 |
| Til | O‘zbek |
| DOI | 10.70626/cardiouz-2026-3-00081 |
DOI: 10.70626/cardiouz-2026-3-00081 · Maqolaning asl sahifasi
hayot sifati, Kanzas-Siti kardiomiopatiya so’rovnomasi, ishemik kardiomiopatiya, to’liq revaskulyarizatsiya, SGLT2 ingibitorlari, quality of life, Kansas City Cardiomyopathy Questionnaire, ischemic cardiomyopathy, complete revascularization, SGLT2 inhibitors, качество жизни, Канзасский опросник по кардиомиопатии, ишемическая кардиомиопатия, полная реваскуляризация, ингибиторы SGLT2
Obstructive sleep apnea syndrome (OSAS) and ischemic heart disease (IHD) frequently coexist as comorbid conditions that mutually exacerbate one another. The aim of this review is to evaluate the impact of OSAS on…
Sudden cardiac death (SCD) in young individuals is a significant medical and social problem, a substantial proportion of which is caused by inherited disorders of myocardial electrical activity. The aim of this review…
Cardiorenometabolic syndrome (CRMS) is one of the most important challenges in modern medicine and is considered a leading cause of morbidity and mortality worldwide. Major randomized clinical trials conducted over the…
Lipid metabolism disorders are one of the leading risk factors for the development of atherosclerotic cardiovascular diseases and remain of high importance worldwide. Despite substantial advances in reducing low-density…
Cardiorenometabolic syndrome (CRMS) is a multifactorial clinical condition reflecting complex and interrelated pathobiological processes involving the cardiovascular, renal, and metabolic systems. Its central mechanisms…
Chronic coronary syndrome (CCS) remains one of the leading causes of mortality and disability worldwide, particularly in Central Asian countries and the Republic of Uzbekistan. This review presents a contemporary…
Non-obstructive angina and ischemia of the coronary arteries (ANOCA/INOCA) is a condition in which there are signs of angina and/or ischemia in the absence of significant obstruction of the coronary arteries. This…
Patient registries following acute myocardial infarction (AMI) and stroke are a key tool for quality control, real-world clinical practice research, and secondary prevention management. This article examines…
Aim: To evaluate the effect of combined antihypertensive therapy on arterial blood pressure parameters in pregnant women with uncontrolled gestational arterial hypertension. Materials and methods: The study included 60…
Aim. To determine the association between polymorphisms of the PITX2 (rs6817105) and KCNN3 (rs13376333) genes and the development of atrial fibrillation (AF) in patients with arterial hypertension (AH) in the Uzbek…